GLP-1 Healthy Weight Study
A parallel-group, double-blinded study to investigate the safety and tolerability of a GLP-1 product compared to placebo in generally healthy adult participants aged 55 to 80 Years with a BMI of 22 to 25 kg/m2. Involves up to 20 visits over a 60-week period. The study procedures include, but are not limited to, oral study product use, blood draws, body scans, glucose testing, and questionnaires/diaries.